Irena Loryan

981 total citations
33 papers, 624 citations indexed

About

Irena Loryan is a scholar working on Oncology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Irena Loryan has authored 33 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Psychiatry and Mental health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Irena Loryan's work include Drug Transport and Resistance Mechanisms (12 papers), Epilepsy research and treatment (11 papers) and Neuroscience and Neuropharmacology Research (8 papers). Irena Loryan is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Epilepsy research and treatment (11 papers) and Neuroscience and Neuropharmacology Research (8 papers). Irena Loryan collaborates with scholars based in Sweden, United States and Netherlands. Irena Loryan's co-authors include Margareta Hammarlund‐Udenaes, Markus Fridén, Magnus Ingelman‐Sundberg, M. Lindqvist, Jan Jakobsson, Inger Johansson, Claire Mackie, Achiel Van Peer, Donald Heald and Wilhelmus Drinkenburg and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecular Psychiatry.

In The Last Decade

Irena Loryan

32 papers receiving 610 citations

Peers

Irena Loryan
Arthur R. Smith United States
Angela C. Doran United States
Stacey L. Becker United States
David J. Sequeira United States
Aude Jacob France
Leesa Bryant United States
Irena Loryan
Citations per year, relative to Irena Loryan Irena Loryan (= 1×) peers Sandrine Dauchy

Countries citing papers authored by Irena Loryan

Since Specialization
Citations

This map shows the geographic impact of Irena Loryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Loryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Loryan more than expected).

Fields of papers citing papers by Irena Loryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Loryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Loryan. The network helps show where Irena Loryan may publish in the future.

Co-authorship network of co-authors of Irena Loryan

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Loryan. A scholar is included among the top collaborators of Irena Loryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Loryan. Irena Loryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ioannidis, Konstantinos, Elisabet I. Nielsen, Lamprini Galani, et al.. (2024). Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF). International Journal of Antimicrobial Agents. 65(1). 107394–107394. 4 indexed citations
2.
Mahajan, Jai Kumar, et al.. (2024). Active CNS delivery of oxycodone in healthy and endotoxemic pigs. Fluids and Barriers of the CNS. 21(1). 86–86. 2 indexed citations
3.
Hu, Yang, et al.. (2024). Region-independent active CNS net uptake of marketed H+/OC antiporter system substrates. Frontiers in Cellular Neuroscience. 18. 1493644–1493644. 1 indexed citations
4.
Hammarlund‐Udenaes, Margareta, et al.. (2024). Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics. Fluids and Barriers of the CNS. 21(1). 95–95. 1 indexed citations
5.
Kristensen, Mie, et al.. (2024). Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action. The Journal of Headache and Pain. 25(1). 187–187. 2 indexed citations
6.
Hu, Yang, et al.. (2024). Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy. Frontiers in Pharmacology. 15. 1486686–1486686. 2 indexed citations
7.
Balayssac, David, Jérôme Busserolles, Damien Richard, et al.. (2023). Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project. Biomedicine & Pharmacotherapy. 167. 115535–115535. 5 indexed citations
9.
Fredriksson, Robert, Fabien Gosselet, Maxime Culot, et al.. (2023). Differential Blood–Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro. Pharmaceutics. 15(5). 1507–1507. 7 indexed citations
10.
Miller, Kaitlin C., Natalie Hudson, Michelle E. Pizzo, et al.. (2022). Brain barriers virtual: an interim solution or future opportunity?. Fluids and Barriers of the CNS. 19(1). 19–19. 1 indexed citations
11.
Loryan, Irena, Andreas Reichel, Bo Feng, et al.. (2022). Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical Research. 39(7). 1321–1341. 62 indexed citations
12.
Vallianatou, Theodosia, Anna Nilsson, Mohammadreza Shariatgorji, et al.. (2021). Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier. Molecular Psychiatry. 26(12). 7732–7745. 20 indexed citations
13.
Andronis, Christos, João Pedro Silva, Helena Carmo, et al.. (2020). Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis. Archives of Toxicology. 94(8). 2829–2845. 11 indexed citations
14.
Syvänen, Stina, Margareta Hammarlund‐Udenaes, & Irena Loryan. (2020). In Vivo Studies of Drug BBB Transport: Translational Challenges and the Role of Brain Imaging. Handbook of experimental pharmacology. 273. 223–244. 1 indexed citations
15.
16.
18.
Loryan, Irena, Vikash Sinha, Claire Mackie, et al.. (2014). Mechanistic Understanding of Brain Drug Disposition to Optimize the Selection of Potential Neurotherapeutics in Drug Discovery. Pharmaceutical Research. 31(8). 2203–2219. 52 indexed citations
19.
Haslemo, Tore, Irena Loryan, N. Ueda, et al.. (2012). UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems. Clinical Pharmacology & Therapeutics. 92(2). 221–227. 28 indexed citations
20.
Loryan, Irena, M. Lindqvist, Inger Johansson, et al.. (2011). Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia. European Journal of Clinical Pharmacology. 68(4). 397–406. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026